Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis
Public ClinicalTrials.gov record NCT03926637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Feasibility of the Multiple Sclerosis Performance Test for Assessment of Functional Performance Measures in Patients With Multiple Sclerosis
Study identification
- NCT ID
- NCT03926637
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 3,073 participants
Conditions and interventions
Conditions
Interventions
- Multiple Sclerosis Performance Test (MSPT) Other
Other
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2019
- Primary completion
- Dec 4, 2022
- Completion
- Dec 4, 2022
- Last update posted
- Jan 29, 2023
2019 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Berkeley | California | 94705 | — |
| Research Site | Los Angeles | California | 90033-5310 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Washington D.C. | District of Columbia | 20007 | — |
| Research Site | Atlanta | Georgia | 30309 | — |
| Research Site | Atlanta | Georgia | 30327 | — |
| Research Site | Chicago | Illinois | 60008 | — |
| Research Site | Boston | Massachusetts | 02215 | — |
| Research Site | Farmington Hills | Michigan | 48334 | — |
| Research Site | Owosso | Michigan | 48867 | — |
| Research Site | St Louis | Missouri | 63131 | — |
| Research Site | Teaneck | New Jersey | 07666 | — |
| Research Site | Buffalo | New York | 14202 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Portland | Oregon | 97225 | — |
| Research Site | Philadelphia | Pennsylvania | 19104 | — |
| Research Site | Pittsburgh | Pennsylvania | 15212 | — |
| Research Site | Dallas | Texas | 75390-8806 | — |
| Research Site | Salt Lake City | Utah | 84103 | — |
| Research Site | Seattle | Washington | 98122 | — |
| Research Site | Spokane | Washington | 99208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03926637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03926637 live on ClinicalTrials.gov.